CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efFicacy and safely or idelalisib (GS-1101) in combination with bendamustine and Minimal) for previously treated chronic lymphocytic leukemia (CLL).
Author
Barrlentos Jacqueline Claudia
Brown Jennifer R.
+18 more
Colffier Bertrand
Delgado Julio
Eradat Herbert Aaron
Evans Shelley
Farber Charles Michael
Ghia Paolo
Hallek Michael J.
Hillmen Peter
Jacob Abraham
Jahn Thomas Michael
Loscertales Javier
MacDonald Donald
Omyla-Staszewska Joanna
Pristupa Alexander S.
Robak Tadeusz
Schuh Anna
Sharman Jeff Porter
Zelenetz Andrew David
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
01/01/2014
Field of study
No full text
Kölner UniversitätsPublikationsServer